Abstract Number: 2813 • 2018 ACR/ARHP Annual Meeting
Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials
Background/Purpose: Selective Estrogen Receptor Modulators (SERMs) are one of the available treatment options for postmenopausal osteoporosis. Since Raloxifene was first introduced on 1997 for post-menopausal…